TESTS

European patent · EP2856161 · In force

Register entry

Publication number
EP2856161
Application number
EP13734141
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 31, 2013
Published
Apr 8, 2015
Granted
Apr 18, 2018
Protection ends at the latest
May 30, 2033
Next annual fee due
May 31, 2027
IPC classes
G01N 33/542 (2006.01)
C07K 14/72 (2006.01)
G01N 33/566 (2006.01)
Priority
US 201261654265 P 01.06.2012
PCT application
PCT/GB2013/051464 31.05.2013
PCT publication
WO2013/179062 05.12.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jul 5, 2024

    Address changed

    Owner
    Heptares Therapeutics Limited, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, United Kingdom → Nxera Pharma UK Limited, Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6DG, United Kingdom

    Published in Swissreg on 05.07.2024

  4. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  5. Jun 2, 2023

    Change

    Published in Swissreg on 02.06.2023

  6. Jun 19, 2018

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 19.06.2018

  7. Apr 18, 2018

    Granted

    Published in Swissreg on 18.04.2018

Parties

Inventor

MARSHALL, Fiona Hamilton

Welwyn Garden City Hertfordshire AL7 3AX, GB

JAZAYERI-DEZFULY, Seyed Ali

Welwyn Garden City Hertfordshire AL7 3AX, GB

PATEL, Jayesh Chhotubhai

Welwyn Garden City Hertfordshire AL7 3AX, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.